167 related articles for article (PubMed ID: 21902632)
1. Nucleic acid-based technologies in therapy of malignant gliomas.
Piwecka M; Rolle K; Wyszko E; Żukiel R; Nowak S; Barciszewska MZ; Barciszewski J
Curr Pharm Biotechnol; 2011 Nov; 12(11):1805-22. PubMed ID: 21902632
[TBL] [Abstract][Full Text] [Related]
2. Promising human brain tumors therapy with interference RNA intervention (iRNAi).
Rolle K; Nowak S; Wyszko E; Nowak M; Zukiel R; Piestrzeniewicz R; Gawronska I; Barciszewska MZ; Barciszewski J
Cancer Biol Ther; 2010 Mar; 9(5):396-406. PubMed ID: 20118657
[TBL] [Abstract][Full Text] [Related]
3. A multivariate analysis of patients with brain tumors treated with ATN-RNA.
Wyszko E; Rolle K; Nowak S; Zukiel R; Nowak M; Piestrzeniewicz R; Gawrońska I; Barciszewska MZ; Barciszewski J
Acta Pol Pharm; 2008; 65(6):677-84. PubMed ID: 19172848
[TBL] [Abstract][Full Text] [Related]
4. RNAi based approaches to the treatment of malignant glioma.
Mathupala SP; Guthikonda M; Sloan AE
Technol Cancer Res Treat; 2006 Jun; 5(3):261-9. PubMed ID: 16700622
[TBL] [Abstract][Full Text] [Related]
5. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas.
Hau P; Kunz-Schughart LA; Rümmele P; Arslan F; Dörfelt A; Koch H; Lohmeier A; Hirschmann B; Müller A; Bogdahn U; Bosserhoff AK
J Neurooncol; 2006 Mar; 77(1):1-7. PubMed ID: 16292494
[TBL] [Abstract][Full Text] [Related]
6. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.
Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C
Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728
[TBL] [Abstract][Full Text] [Related]
7. Nucleic acids-based therapeutics in the battle against pathogenic viruses.
Haasnoot J; Berkhout B
Handb Exp Pharmacol; 2009; 189(189):243-63. PubMed ID: 19048203
[TBL] [Abstract][Full Text] [Related]
8. miRNA Multiplayers in glioma. From bench to bedside.
Rolle K
Acta Biochim Pol; 2015; 62(3):353-65. PubMed ID: 26307768
[TBL] [Abstract][Full Text] [Related]
9. Magnetic Nanoparticles as a Carrier of dsRNA for Gene Therapy.
Grabowska M; Grześkowiak BF; Rolle K; Mrówczyński R
Methods Mol Biol; 2021; 2211():69-81. PubMed ID: 33336271
[TBL] [Abstract][Full Text] [Related]
10. SiRNA-mediated knockdown against NUF2 suppresses tumor growth and induces cell apoptosis in human glioma cells.
Huang SK; Qian JX; Yuan BQ; Lin YY; Ye ZX; Huang SS
Cell Mol Biol (Noisy-le-grand); 2014 Nov; 60(4):30-6. PubMed ID: 25481014
[TBL] [Abstract][Full Text] [Related]
11. Emerging roles of microRNA in modulating cell-death processes in malignant glioma.
Palumbo S; Miracco C; Pirtoli L; Comincini S
J Cell Physiol; 2014 Mar; 229(3):277-86. PubMed ID: 23929496
[TBL] [Abstract][Full Text] [Related]
12. Nano-mediated delivery of double-stranded RNA for gene therapy of glioblastoma multiforme.
Grabowska M; Grześkowiak BF; Szutkowski K; Wawrzyniak D; Głodowicz P; Barciszewski J; Jurga S; Rolle K; Mrówczyński R
PLoS One; 2019; 14(3):e0213852. PubMed ID: 30889203
[TBL] [Abstract][Full Text] [Related]
13. RNAi: a novel antisense technology and its therapeutic potential.
Dallas A; Vlassov AV
Med Sci Monit; 2006 Apr; 12(4):RA67-74. PubMed ID: 16572063
[TBL] [Abstract][Full Text] [Related]
14. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
15. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.
Liu J; Xu J; Li H; Sun C; Yu L; Li Y; Shi C; Zhou X; Bian X; Ping Y; Wen Y; Zhao S; Xu H; Ren L; An T; Wang Q; Yu S
Oncotarget; 2015 Oct; 6(30):29129-42. PubMed ID: 26320176
[TBL] [Abstract][Full Text] [Related]
16. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
[TBL] [Abstract][Full Text] [Related]
17. Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation.
Purow BW; Haque RM; Noel MW; Su Q; Burdick MJ; Lee J; Sundaresan T; Pastorino S; Park JK; Mikolaenko I; Maric D; Eberhart CG; Fine HA
Cancer Res; 2005 Mar; 65(6):2353-63. PubMed ID: 15781650
[TBL] [Abstract][Full Text] [Related]
18. Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
Schliesser MG; Claus R; Hielscher T; Grimm C; Weichenhan D; Blaes J; Wiestler B; Hau P; Schramm J; Sahm F; Weiß EK; Weiler M; Baer C; Schmidt-Graf F; Schackert G; Westphal M; Hertenstein A; Roth P; Galldiks N; Hartmann C; Pietsch T; Felsberg J; Reifenberger G; Sabel MC; Winkler F; von Deimling A; Meisner C; Vajkoczy P; Platten M; Weller M; Plass C; Wick W
Oncotarget; 2016 Dec; 7(50):82028-82045. PubMed ID: 27880937
[TBL] [Abstract][Full Text] [Related]
19. RNA interference (RNAi)-based therapeutics for treatment of rare neurologic diseases.
Germain ND; Chung WK; Sarmiere PD
Mol Aspects Med; 2023 Jun; 91():101148. PubMed ID: 36257857
[TBL] [Abstract][Full Text] [Related]
20. Antisense oligonucleotides as innovative therapeutic strategy in the treatment of high-grade gliomas.
Caruso G; Caffo M; Raudino G; Alafaci C; Salpietro FM; Tomasello F
Recent Pat CNS Drug Discov; 2010 Jan; 5(1):53-69. PubMed ID: 19832690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
